Skip to main content

Weight Loss (Obesity / Overweight) News (Page 25)

Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications

FDA Medwatch Alert: FDA Issues Warning About Compounded Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss

On May 30, 2023, the FDA posted information about medications containing semaglutide marketed for type 2 diabetes or weight loss. There are currently three FDA-approved semaglutide products which are...

FDA Approves Once-Weekly Wegovy injection for the Treatment of Obesity in Teens Aged 12 Years and Older

New indication based on clinical trial that demonstrated a 16.1% reduction in body mass index (BMI) in teens with obesity treated with Wegovy® (semaglutide) injection 2.4 mg compared to placebo ...

FDA Approves Qsymia for Chronic Weight Management in Certain Pediatric Patients Aged 12 years and Older

June 27, 2022 – The U.S. Food and Drug Administration has approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules) for chronic weight management in...

Rhythm Pharmaceuticals Announces FDA Approval of Imcivree (setmelanotide) for Use in Patients with Bardet-Biedl Syndrome

Imcivree now available for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic or syndromic obesity due to Bardet-Biedl syndrome First and only...

FDA Approves Wegovy (semaglutide) to Treat Adults with Obesity

PLAINSBORO, N.J., June 4, 2021 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy™ (semaglutide) injec...

Obesity a Big Risk Factor for Severe COVID-19, Study Confirms

MONDAY, March 8, 2021 – Yet another study confirms what doctors have long known: Being obese greatly raises the odds that if you contract COVID-19, your case could be a severe one. The study, from...

FDA Approves Saxenda (liraglutide) for the Treatment of Obesity in Adolescents Aged 12-17

PLAINSBORO, N.J., Dec. 4, 2020 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved an updated label for Saxenda® (liraglutide) injection 3 mg for use...

FDA Approves Imcivree (setmelanotide) for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

BOSTON, Nov. 27, 2020 (GLOBE NEWSWIRE) – Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic...

FDA Medwatch Alert: Living Well Remedies, LLC Issues Voluntary Nationwide Recall of Weight Away Remedy, Lot # 111417LWL614, Due To Microbial Contamination

FOR IMMEDIATE RELEASE – Franklin Lakes, NJ, Living Well Remedies, LLC is voluntarily recalling Weight Away Remedy lot# 111417LWL614 to the consumer level. The independent manufacturing facility that p...

FDA Medwatch Alert: HCG (Human Chorionic Gonadotropin) Freeze Dried Vials by Synergy Rx: Recall - Lack of Sterility Assurance

[Posted 02/15/2017] ISSUE: Synergy Rx Pharmacy recalled all lots of Human Chorionic Gonadotropin (HCG) 5,000 units/vial and 11,000 units/vial to the retail level due to a lack of sterility...

KVK Tech Announces FDA-Approval of Lomaira (phentermine hydrochloride USP) for Weight Reduction

NEWTOWN, Pa., Sept. 20, 2016 /PRNewswire/ – KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira (phentermine hydrochloride USP) 8 mg tablets CIV, a...

Eisai Inc. and Arena Pharmaceuticals Announce FDA Approval of Belviq XR (lorcaserin HCl) Extended-Release Tablets

WOODCLIFF LAKE, N.J. and SAN DIEGO, July 19, 2016 /PRNewswire/ – Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the U.S. Food and Drug Administration (FDA) has...

FDA Approves Saxenda (liraglutide [rDNA origin] injection) for Obesity

December 23, 2014 – The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a...

FDA Approves Contrave (bupropion/naltrexone) for Weight Management

September 10, 2014 – The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic...

FDA Medwatch Alert: Zi Xiu Tang Bee Pollen Capsules by Guangzhou Zi Xiu Tang Biotechnology Co., Ltd: Warning - Undeclared Drug Ingredients

ISSUE: FDA has tested multiple Zi Xiu Tang Bee Pollen products from various distributors in the United States (US). All products that have been tested, including those that claim to be “genuine” and “...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, Adipex-P, tirzepatide, Alli, orlistat, garcinia cambogia, desvenlafaxine, dulaglutide